The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $58.70 in the prior trading day, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) closed at $58.27, down -0.73%. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 3.29 million shares were traded.
Ratios:
Our goal is to gain a better understanding of BMRN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.90. For the most recent quarter (mrq), Quick Ratio is recorded 3.49 and its Current Ratio is at 5.52. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’25 when Hubbard Cristin sold 273 shares for $64.92 per share. The transaction valued at 17,723 led to the insider holds 32,700 shares of the business.
Hubbard Cristin bought 273 shares of BMRN for $17,723 on May 02 ’25. On Mar 19 ’25, another insider, Burkhart Erin, who serves as the GVP, Chief Accounting Officer of the company, sold 1,295 shares for $71.52 each. As a result, the insider received 92,618 and left with 16,955 shares of the company.
Valuation Measures:
As of this moment, Biomarin’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.62, and their Forward P/E ratio for the next fiscal year is 13.37. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.82 while its Price-to-Book (P/B) ratio in mrq is 1.93.
Stock Price History:
Over the past 52 weeks, BMRN has reached a high of $94.85, while it has fallen to a 52-week low of $52.93. The 50-Day Moving Average of the stock is -9.90%, while the 200-Day Moving Average is calculated to be -16.45%.
Shares Statistics:
A total of 191.76M shares are outstanding, with a floating share count of 188.20M. Insiders hold about 1.86% of the company’s shares, while institutions hold 96.26% stake in the company.
